Intravenous glutamate reduced the risk of developing severe circulatory failure after isolated coronary artery bypass graft surgery (CABG) for acute coronary syndrome (ACS) in a double-blind randomised clinical trial ( Identifier:NCT00489827). Here our aim was to study if glutamate was associated with reduced the use of inotropes. |